LIVER SPECIFIC DELETION OF TM6SF2 PROMOTES BOTH HEPATIC FIBROSIS AND HEPATOCELLULAR CANCER

被引：0
|
作者：
Newberry, Elizabeth P.
Hall, Zoe
Xie, Yan
Molitor, Elizabeth A.
Brunt, Elizabeth M.
Griffin, Jules
Davidson, Nicholas O.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
324
引用
收藏
页码：S1267 / S1267
页数：1
相关论文
共 50 条
  • [21] Tm6sf2 is a Regulator of Liver Fat Metabolism in Smooth Er Influencing Vldl Lipidation
    Luo, Fei
    Hobbs, Helen H.
    Cohen, Jonathan C.
    CIRCULATION, 2020, 142
  • [22] Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
    Zhang, Yating
    Xie, Mingxu
    Wen, Jun
    Liang, Cong
    Song, Qian
    Liu, Weixin
    Liu, Yali
    Song, Yang
    Lau, Harry Cheuk Hay
    Cheung, Alvin Ho-Kwan
    Man, Kwan
    Yu, Jun
    Zhang, Xiang
    GUT, 2024,
  • [23] TM6SF2: A novel target for plasma lipid regulation
    Li, Ting-Ting
    Li, Tao-Hua
    Peng, Juan
    He, Bei
    Liu, Lu-Shan
    Wei, Dang-Heng
    Jiang, Zhi-Sheng
    Zheng, Xi-Long
    Tang, Zhi-Han
    ATHEROSCLEROSIS, 2018, 268 : 170 - 176
  • [24] TM6SF2 rs58542926 Impacts Lipid Processing in Liver and Small Intestine
    O'Hare, Elizabeth A.
    Yang, Rongze
    Yerges-Armstrong, Laura M.
    Sreenivasan, Urmila
    McFarland, Rebecca
    Leitch, Carmen C.
    Wilson, Meredith H.
    Narina, Shilpa
    Gorden, Alexis
    Ryan, Kathy A.
    Shuldiner, Alan R.
    Farber, Steve A.
    Wood, G. Craig
    Still, Christopher D.
    Gerhard, Glenn S.
    Robishaw, Janet D.
    Sztalryd, Carole
    Zaghloul, Norann A.
    HEPATOLOGY, 2017, 65 (05) : 1526 - 1542
  • [25] Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Tse, Chi-Hang
    Chan, Henry Lik-Yuen
    JOURNAL OF HEPATOLOGY, 2014, 61 (03) : 708 - 709
  • [26] PNPLA3 and TM6SF2 Risk Alleles Amplify Effects of Diet on Hepatic Steatosis
    Chen, Vincent L.
    Du, Xiaomeng
    Chen, Yanhua
    Kuppa, Annapurna
    Halligan, Brian
    Speliotes, Elizabeth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S549 - S549
  • [27] The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
    Anstee, Quentin M.
    Day, Christopher P.
    SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 270 - 290
  • [28] Defects in TM6SF2 Impairs Lipidation of Nascent VLDL and Leads to Accumulation of Liver Fat
    Martin, Sarah A.
    Smagris, Eriks
    Cohen, Jonathan C.
    Hobbs, Helen H.
    FASEB JOURNAL, 2018, 32 (01):
  • [29] Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line
    Pant, Asmita
    Chen, Yue
    Kuppa, Annapurna
    Du, Xiaomeng
    Halligan, Brian D.
    Speliotes, Elizabeth K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [30] Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
    Luo, Fei
    Smagris, Eriks
    Martin, Sarah A.
    Vale, Goncalo
    McDonald, Jeffrey G.
    Fletcher, Justin A.
    Burgess, Shawn C.
    Hobbs, Helen H.
    Cohen, Jonathan C.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 13 (03): : 879 - 899
12345